SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-023270
Filing Date
2021-09-21
Accepted
2021-09-21 16:30:10
Documents
12
Period of Report
2021-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 31403
  Complete submission text file 0001493152-21-023270.txt   204667

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE aim-20210920.xsd EX-101.SCH 3025
3 XBRL LABEL FILE aim-20210920_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE aim-20210920_pre.xml EX-101.PRE 22790
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 211266814
SIC: 2836 Biological Products, (No Diagnostic Substances)